|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Angiotensin-Converting Enzyme 2 (ACE2) ELISA | Anti-Spermatoza (Serum) ELISA | Anti-Ustekinumab (Stelara®) ELISA | GLP-1 (Active Form) ELISA Assay | IGF-1 ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB08019 | IB79154 | TM09036 | 27784 | E20 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Human Angiotensin-converting enzyme 2 (ACE2) ELISA has been designed for the detection of human ACE2 in serum, plasma, tissue homogenates or other biological fluids. For research use only, not for use in diagnostic procedures. | Enzyme linked immunosorbent assay (ELISA) for the determination of antibodies directed against human spermatozoa in serum. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich ELISA for the determination of active form of GLP-1 (GLP-1 (7-36) amide and GLP-1 (7-37)) in EDTA plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of levels of IGF-I in serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Angiotensin-Converting Enzyme 2 (ACE2) | Anti-Spermatoza | sAPP Total | CMV IgM | Alpha-Klotho (Soluble) |
| Sample Type | Serum, plasma, tissue homogenates and other biological fluids. | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum | Serum, plasma (EDTA, Heparin, Citrate), urine and cell culture supernatant |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.391 – 25 ng/mL | 31 to 250 U/mL | Anti-Ustekinumab (Stelara®) | 1.25 to 80 pmol/L | 2 to 50 ng/mL |
| Sensitivity | 0.234 ng/mL | Limit of Detection (LoD): 8.553 U/mL | 0.06 ng/mL | Inquire | 6.15 pg/mL |
| Assay Time | 90 min. incubation (37°C) + 60 min. (37°C) + 30 min. (37°C) + 20 min. (37°C) = 3 hours, 20 min. total incubation time. | 2 hrs (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs 30 mins (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |